These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3907149

  • 21. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. (+)-cyanidanol-3.
    Lancet; 1982 Mar 06; 1(8271):549. PubMed ID: 6120400
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A clinical and ultrastructural study of osteogenesis imperfecta after flavonoid (Catergen) therapy.
    Jones CJ, Cummings C, Ball J, Beighton P.
    S Afr Med J; 1984 Dec 15; 66(24):907-10. PubMed ID: 6505901
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J, Toncsev H, Sréter L, Cornides A, Kiss A.
    Int J Tissue React; 1984 Dec 15; 6(1):75-80. PubMed ID: 6715121
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W, Leube G.
    Med Klin; 1978 Oct 13; 73(41):1432-6. PubMed ID: 703670
    [Abstract] [Full Text] [Related]

  • 36. [Catergen in the treatment of chronic liver diseases].
    Semendiaeva ME, Eremeeva EP, Kodrian AA, Kamaeva NG.
    Sov Med; 1986 Oct 13; (9):47-50. PubMed ID: 3541245
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S, Halpern Z, Gutman M, Shpirer Z, Baratz M, Bass D.
    Gut; 1985 Sep 13; 26(9):975-9. PubMed ID: 3896964
    [Abstract] [Full Text] [Related]

  • 39. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
    World MJ, Aps EJ, Shaw GK, Thomson AD.
    Alcohol Alcohol; 1984 Sep 13; 19(1):23-9. PubMed ID: 6149758
    [Abstract] [Full Text] [Related]

  • 40. (+)-Cyanidanol-3 in acute viral hepatitis.
    Di Nola F.
    Lancet; 1984 Sep 13; 2(8208-8209):1379-80. PubMed ID: 6109203
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.